Mylan Attacks Newly Issued Oracea Patent
Mylan Pharmaceuticals Inc. has sued Galderma Laboratories Inc. in an effort to invalidate the drugmaker's newly issued patent related to rosacea treatment Oracea, marking the latest development in the companies' battle...To view the full article, register now.
Already a subscriber? Click here to view full article